These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37632078)

  • 1. Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy.
    Lv S; Wang Y; Jiang K; Guo X; Zhang J; Zhou F; Li Q; Jiang Y; Yang C; Teng T
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
    Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering therapeutic phages for enhanced antibacterial efficacy.
    Meile S; Du J; Dunne M; Kilcher S; Loessner MJ
    Curr Opin Virol; 2022 Feb; 52():182-191. PubMed ID: 34952266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy.
    Lewis JM; Williams J; Sagona AP
    Biochem Soc Trans; 2024 Jun; 52(3):1373-1384. PubMed ID: 38716972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic phage and its application in phage therapy.
    Kumar A; Yadav A
    Prog Mol Biol Transl Sci; 2023; 200():61-89. PubMed ID: 37739560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Creation of synthetic bacterial viruses].
    Ando H
    Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Bacteriophages as Versatile Biologics.
    Kilcher S; Loessner MJ
    Trends Microbiol; 2019 Apr; 27(4):355-367. PubMed ID: 30322741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing phage therapy through the lens of virus host-breadth and emergence potential.
    Bono LM; Mao S; Done RE; Okamoto KW; Chan BK; Turner PE
    Adv Virus Res; 2021; 111():63-110. PubMed ID: 34663499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
    Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Milagro: a platform for engineering a broad host range virulent phage for
    Yao G; Le T; Korn AM; Peterson HN; Liu M; Gonzalez CF; Gill JJ
    J Virol; 2023 Nov; 97(11):e0085023. PubMed ID: 37943040
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancing phage therapy through synthetic biology and genome engineering.
    Lenneman BR; Fernbach J; Loessner MJ; Lu TK; Kilcher S
    Curr Opin Biotechnol; 2021 Apr; 68():151-159. PubMed ID: 33310655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flagellotropic Bacteriophages: Opportunities and Challenges for Antimicrobial Applications.
    Esteves NC; Scharf BE
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Engineering and Rebooting of Bacteriophages in L-Form Bacteria.
    Fernbach J; Meile S; Kilcher S; Loessner MJ
    Methods Mol Biol; 2024; 2734():247-259. PubMed ID: 38066374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
    Zurabov F; Zhilenkov E
    Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.